Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
4,510.00
-40.00 (-0.88%)
At close: Jun 19, 2026
Sinsin Pharmaceutical Market Cap
Sinsin Pharmaceutical has a market cap or net worth of 68.42 billion as of June 18, 2026. Its market cap has decreased by -26.43% in one year.
Market Cap
68.42B
Enterprise Value
104.57B
Revenue
118.65B
Ranking
n/a
PE Ratio
6.13
Stock Price
4,510.00
Market Cap Chart
Since February 28, 2017, Sinsin Pharmaceutical's market cap has decreased from 121.67B to 68.42B, a decrease of -43.77%. That is a compound annual growth rate of -6.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 68.42B | -23.04% |
| Dec 30, 2025 | 88.90B | 7.92% |
| Dec 30, 2024 | 82.38B | -12.98% |
| Dec 28, 2023 | 94.66B | 11.83% |
| Dec 29, 2022 | 84.65B | -13.49% |
| Dec 30, 2021 | 97.85B | -29.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samik Pharmaceutical Company LTD. | 84.16B |
| Sam-A Pharm. | 81.36B |
| Pharos iBio | 81.04B |
| Daehan Nupharm | 79.58B |
| Organoidsciences | 71.72B |
| GL Pharm Tech | 69.72B |
| Hwail Pharmaceutical | 67.26B |
| Optipharm.CO.,LTD | 67.12B |